Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

202122232425262728

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

17th Nov 2023 08:31

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer. Read More

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

17th Nov 2023 07:58

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell. Read More

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

14th Nov 2023 10:51

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint. Read More

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

13th Nov 2023 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

9th Nov 2023 12:06

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data. Read More

Lancashire Holdings declares special dividend after strong year so far

9th Nov 2023 11:02

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date. Read More

AstraZeneca turns up heat in Nordisk-dominated weight loss drug space

9th Nov 2023 10:10

(Alliance News) - AstraZeneca PLC on Thursday said it struck a licence deal in the weight loss drug space, giving something to think about for Novo Nordisk AS, whose Ozempic and Wegovy products have laid down the gauntlet for the rest of the pharma space. Read More

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

9th Nov 2023 09:23

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu. Read More

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

9th Nov 2023 08:57

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade. Read More

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

9th Nov 2023 07:48

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood. Read More

AstraZeneca plans next phase of trial on kidney drug combination data

3rd Nov 2023 17:06

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria. Read More

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

3rd Nov 2023 11:34

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy. Read More

UK earnings, trading statements calendar - next 7 days

2nd Nov 2023 15:57

Read More

AstraZeneca launches collaboration and investment deal with Cellectis

1st Nov 2023 08:59

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis. Read More

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

30th Oct 2023 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

25th Oct 2023 11:04

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday. Read More

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

24th Oct 2023 17:08

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment. Read More

AstraZeneca says US accepts self-administered flu vaccine for review

24th Oct 2023 11:06

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light. Read More

AstraZeneca celebrates drug trial results for cancer indications

23rd Oct 2023 17:50

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer. Read More

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

23rd Oct 2023 17:08

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama. Read More

202122232425262728
FTSE 100 Latest
Value9,491.25
Change63.52